On Monday, Fulcrum Therapeutics Inc (FULC) stock saw a modest uptick, ending the day at $3.03 which represents a slight increase of $0.02 or 0.66% from the prior close of $3.01. The stock opened at $3 ...

Aclaris Therapeutics has secured an exclusive licence from Biosion for the global rights to two new antibodies, BSI-045B and ...

On Monday, 10X Genomics Inc (TXG) stock saw a decline, ending the day at $13.18 which represents a decrease of $-0.16 or -1.20% from the prior close of $13.34. The stock opened at $13.34 and touched a ...

Equities researchers at Leerink Partnrs reduced their FY2024 earnings per share estimates for shares of Lexeo Therapeutics in ...

The good news from Monday’s results, according to Leerink Partners’ David Risinger, is that icotrokinra’s efficacy seems ...

CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling ...

Research analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of Ardent Health Partners in a ...

Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on November 12. The company’s ...

Fintel reports that on November 13, 2024, Leerink Partners downgraded their outlook for 908 Devices (NasdaqGM:MASS) from ...

In a report released yesterday, Daina Graybosch from Leerink Partners maintained a Hold rating on Turnstone Biologics Corp. (TSBX – ...

Leerink Partners, the health-care advisory firm, has continued a recent recruitment drive with hires from boutiques ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...